Hormonal therapies
HavaH is developing these therapies for women worldwide, with the stated aim of improving quality of life.
Source: LinkedIn company description · Retrieved October 13, 2026
HavaH develops therapies aimed at early prevention of breast cancers, including hormonal refractory ER+ and metastatic cancer.
Havah uses targeted modulation of hormonal balance in the breast, aiming for more nuanced hormonal regulation than traditional hormonal therapies. HavaH is developing proprietary hormonal therapies intended to improve quality of life for women worldwide.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
HavaH is developing these therapies for women worldwide, with the stated aim of improving quality of life.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.